TP53 and prostate carcinoma: This analysis showed the involvement of HSP27 in several pathways such as apoptosis, VEGF, RAS, MAPK, metabolism, cell cycle, TP53, prostate cancer, PI3K/AKT, and transcriptional misregulation in the cancer pathway (Table S2).